Patients With AFib
Are at an Increased
Risk of Stroke.
When blood thinners (anticoagulants) aren’t enough or cause issues that affect your quality of life, left atrial appendage occlusion (LAAO) therapy might be an option.
An LAAO procedure seals off the left atrial appendage, preventing blood clots from entering the bloodstream. It provides a safe and effective alternative for patients who cannot tolerate long-term use of blood thinners.
Clinical Trial Participants
Contact your physician or enrolling site coordinator for a full list of eligibility criteria. Prior to participating, the clinical staff will review the study risks and benefits and address your questions as part of the informed consent process. As part of the trial, you will have several responsibilities.
Eligibility Requirements
-
Diagnosed with non-valvular Atrial Fibrillation
-
At an increased risk for stroke and recommended for oral anticoagulation
Participant Responsibilities
-
Provide informed consent
-
Adhere to antiplatelet and/or oral anticoagulant therapy study requirements
-
Commit to specific follow-up and scheduled visits
Choosing to participate in a clinical trial is an important personal decision. Talk with your doctor and family members or friends about deciding to join a clinical trial.
